Background and Purpose: Stroke on awakening (SOA) is denied the benefits of thrombolytic therapy and is typically excluded from acute clinical trials on the grounds that the time of onset is unknown. In this study we compared the clinical characteristics of SOA and of stroke while awake (SWA), particularly in the subgroup of patients seen within a time frame of 6 h after stroke awareness. Material and Methods: Patients were included consecutively in the Stroke Data Bank of the Spanish Neurological Society (BADISEN) that records 365 different items, including vascular risk factors, neurological findings, stroke severity, aetiopathogenic diagnosis and neuroimaging data. Results: A total of 1,248 patients with acute cerebral infarction were included in the study, 301 (24.1%) with SOA and 947 (75.9%) with SWA. The peak time for stroke occurrence was between 6:01 a.m. and 12 noon, both in the whole stroke group and in each aetiopathogenic stroke subtype. Age, sex, stroke risk factors, stroke severity at admission, vital signs and stroke subtypes were not significantly different between SOA and SWA, neither in the group as a whole nor in the group of patients seen within 6 h of stroke recognition. Six hundred and fifty-four patients were seen within the potential 6-hour therapeutic window. In this group, the CT scan on admission was normal in 39.4% of SOA but the ultimate CT/MRI scan showed that 46.2% of these had a territorial infarction (in SWA these same figures were 60.8 and 67.7%, respectively). Conclusion: There are no relevant differences in the clinical, neuroimaging and aetiopathogenic characteristics of SOA and SWA. We should rely on new techniques such as DWI/PWI to indicate the most appropriate treatment in a more rational manner as nearly half of the patients with SOA seen early may benefit from them.

1.
Elliott WJ: Circadian variation in the timing of stroke onset. A meta-analysis. Stroke 1998;29:992–996.
2.
Lago A, Geffner D, Tembl J, Landete L, Valero C, Baquero M: Circadian variation in acute ischemic stroke. A hospital-based study. Stroke 1998;29:1873–1875.
3.
Marsh EE 3rd, Biller J, Adams HP Jr, Marler JR, Hulbert JR, Love RR, Gordon DL: Circadian variation in onset of acute ischemic stroke. Arch Neurol 1990;47:1178–1180.
4.
Argentino C, Toni D, Rasura M, Violi F, Sacchetti ML, Allegretta A, Balsano F, Fieschi C: Circadian variation in the frequency of ischemic stroke. Stroke 1990;21:387–389.
5.
Wroe SJ, Sandercock P, Bamford J, Dennis M, Slattery J, Warlow C: Diurnal variation in incidence of stroke: Oxfordshire community stroke project. BMJ 1992;304:155–157.
6.
Chaturvedi S, Adams HP Jr, Woolson RF: Circadian variation in ischemic stroke subtypes. Stroke 1999;30:1792–1795.
7.
Marshall J: Diurnal variation in occurrence of strokes. Stroke 1977;8:230–231.
8.
Arboix A, Martí-Vilalta JL: Ritmo nictameral y patología vascular cerebral: estudio clínico prospectivo de 206 pacientes. Med Clin 1988;90:358–361.
9.
Marler JR, Price TR, Clarck GL, Muller JE, Robertson T, Mohr JP, Hier DB, Wolf PA, Caplan LR, Foulkes MA: Morning increase in onset of ischemic stroke. Stroke 1989;20:473–476.
10.
Pasqualetti P, Natali G, Casale R, Colantonio D: Epidemiological chronorisk of stroke. Acta Neurol Scand 1990;81:71–74.
11.
Ricci S, Celani MG, Vitali R, La Rosa F, Righetti E, Duca E: Diurnal and seasonal variations in the occurrence of stroke: A community-based study. Neuroepidemiology 1992;11:59–64.
12.
Gallerani M, Manfredini R, Cocorullo A, Goldoni C, Bigoni M, Fersini C: Chronobiological aspects of acute cerebrovascular diseases. Acta Neurol Scand 1993;87:482–487.
13.
Kelly-Hayes M, Wolf PA, Kase CS, Brand FN, McGuirk JM, D’Agostino RB: Temporal patterns of stroke onset: The Framingham study. Stroke 1995;26:1343–1347.
14.
Haapaniemi H, Hillbom M, Juvela S: Weekend and holiday increase in the onset of ischemic stroke in young women. Stroke 1996;27:1023–1027.
15.
Toni D, Argentino C, Gentile M, Sacchetti ML, Girmenia F, Millefiorini E, Fieschi C: Circadian variation in the onset of acute cerebral ischemia: Etiopathogenetic correlates in 80 patients given angiography. Chronobiol Int 1991;8:321–326.
16.
Álvarez-Sabin J, Dávalos A, Martínez-Vila E: BADISEN; Banco de Datos de Ictus de la Sociedad Españla de Neurología (Grupo de Estudio de las Enfermedades Vasculares Cerebrales). Girona, Grafis & Sant, 1996 (http:// www.badisen.net).
17.
von Kummer R, Nolte PN, Schnittger H, Thron A, Ringelstein EB: Detectability of cerebral hemisphere ischaemic infarcts by CT within 6 h of stroke. Neuroradiology 1996;38:31–33.
18.
Damasio H: A CT-guide to the identification of cerebral vascular territories. Arch Neurol 1983;40:138–142.
19.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE: Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial, TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41.
20.
van der Zwan A, Hillen B, Tulleken CAF, Dujovny M, Dragovic L: Variability of the territories of the major cerebral arteries. J Neurosurg 1992;77:927–940.
21.
Wodarz R: Watershed infarctions and computed tomography: A topographical study in cases with stenosis or occlusion of the carotid artery. Neuroradiology 1980;19:245–248.
22.
Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521–1526.
23.
Bassetti C, Aldrich M: Night time versus daytime transient ischaemic attack and ischaemic stroke: A prospective study of 110 patients. J Neurol Neurosurg Psychiatry 1999;67:463–467.
24.
Bornstein NM, Gur AY, Fainshtein P, Korczyn AD: Stroke during sleep: Epidemiological and clinical features. Cerebrovasc Dis 1999;9:320–322.
25.
Iranzo A, Santamaría J, Berenguer J, Sánchez M, Chamorro A: Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology 2002;58:911–916.
26.
Caplan LR, Hier DB, D’Cruz I: Cerebral embolism in the Michael Reese Stroke Registry. Stroke 1983;14:530–536.
27.
Chamorro A, Sacco RL, Mohr JP, Foulkes MA, Kase CS, Tatemichi TK, Wolf PA, Price TR, Hier DB: Clinical-computed tomographic correlations of lacunar infarction in the Stroke Data Bank. Stroke 1991;22:175–181.
28.
Marks MP, Holmgren EB, Fox AJ, Patel S, von Kummer R, Froehlich J: Evaluation of early computed tomographic findings in acute ischemic stroke. Stroke 1999;30:389–392.
29.
von Kummer R: Effect of training in reading CT scans on patient selection for ECASS II. Neurology 1998;51:S50–S52.
30.
Albers GW: Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. Stroke 1999;30:2230–2237.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.